Clinical Trials
173
Active:20
Completed:75
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:6
Phase 2:13
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (150 trials with phase data)• Click on a phase to view related trials
Not Applicable
89 (59.3%)Phase 4
22 (14.7%)Phase 3
19 (12.7%)Phase 2
13 (8.7%)Phase 1
6 (4.0%)Early Phase 1
1 (0.7%)Semaglutide for Smoking Cessation in Patients With Diabetes
Not Applicable
Not yet recruiting
- Conditions
- Diabetes Mellitus, Type 2Nicotine AddictionTobacco Dependence
- Interventions
- First Posted Date
- 2025-07-10
- Last Posted Date
- 2025-07-17
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT07059377
Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)
Not Applicable
Not yet recruiting
- Conditions
- Atrial Fibrillation (AF)Atrial Flutter
- First Posted Date
- 2025-06-03
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 190
- Registration Number
- NCT07002450
- Locations
- 🇨🇦
The Ottawa Hospital Civic Campus, Ottawa, Ontario, Canada
Dapagliflozin for Long COVID Syndrome
Phase 3
Not yet recruiting
- Conditions
- COVID - 19Long COVID Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 192
- Registration Number
- NCT06907251
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
Phase 4
Recruiting
- Conditions
- Tobacco
- Interventions
- Drug: Nicotine Replacement Therapy (Nicotine patch plus NRT gum or lozenge)
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-05-04
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 1500
- Registration Number
- NCT06832085
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
Impact of Automatic Prompts in Echocardiographic Reports on Referral to Cardiology
Not Applicable
Active, not recruiting
- Conditions
- Mitral Regurgitation (MR)Moderate or Severe Aortic Stenosis (AS) (mean Pressure Gradient ≥ 20 Mm Hg or Aortic Valve Area ≤ 1.5 Cm2)
- First Posted Date
- 2025-02-10
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Ottawa Heart Institute Research Corporation
- Target Recruit Count
- 300
- Registration Number
- NCT06816888
- Locations
- 🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 35
- Next
News
No news found